Pharming Group N.V. (PHARM.AS)
EUR 0.8
(-3.32%)
EUR 0.8
(-3.32%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -19.54 Million | 22.89 Million | 36.12 Million | 90.97 Million | 74.55 Million | 46.18 Million |
| Net Income | -9.75 Million | 14.98 Million | 22.03 Million | 47.46 Million | 68.22 Million | 43.45 Million |
| Depreciation & Amortization | 10.18 Million | 13.18 Million | 18.72 Million | 8.94 Million | 5.79 Million | 7.5 Million |
| Deferred income taxes | -45.1 Million | - | -721.22 Thousand | -2.55 Million | - | - |
| Stock-based compensation | 9.25 Million | 6.39 Million | 9.05 Million | 6.53 Million | 4.44 Million | - |
| Change in working capital | -15.48 Million | -387 Thousand | -4.73 Million | -3.25 Million | 3.59 Million | -5.99 Million |
| Other non-cash items | 31.37 Million | -11.28 Million | -7.81 Million | 33.33 Million | -3.06 Million | 1.22 Million |
| Investing Cash Flow | -119.68 Million | 5.32 Million | -20.33 Million | -16.82 Million | -28.24 Million | -4.31 Million |
| Investments in PPE | -1.35 Million | -1.97 Million | -15.95 Million | -16.46 Million | -25.44 Million | -4.31 Million |
| Acquisitions | - | 7.3 Million | - | -354.22 Thousand | -2.8 Million | - |
| Investment purchases | -353.35 Million | - | -4.38 Million | -288 Thousand | -2.5 Million | - |
| Sales/Maturities of investments | 215.34 Million | 6.94 Million | - | - | 2.5 Million | - |
| Other Investing Activities | 19.68 Million | -6.94 Million | - | 288 Thousand | - | - |
| Financing Cash Flow | 2.78 Million | -4.98 Million | -26.67 Million | 65.32 Million | -62.32 Million | -20.54 Million |
| Debt repayment | -5.12 Million | -3.31 Million | -3.14 Million | -63.95 Million | -37.38 Million | -19.89 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 7.52 Million | 2.28 Million | 4.5 Million | 3 Million | 3.11 Million | 12 Million |
| Other Financing Activities | -4.74 Million | -3.95 Million | -28.03 Million | 126.28 Million | -28.05 Million | -12.65 Million |
| Accounts receivables | -17.14 Million | 2.24 Million | 5 Million | -3.49 Million | -8.49 Million | -6.55 Million |
| Accounts payables | 15.01 Million | 11.41 Million | -4.39 Million | 2.56 Million | 8.67 Million | 1.39 Million |
| Inventory | -13.35 Million | -15.01 Million | -5.87 Million | -3.39 Million | 3.43 Million | 1.16 Million |
| Other working capital | -216 Thousand | 969.29 Thousand | 525.63 Thousand | 1.06 Million | -21.45 Thousand | -7.16 Million |
| Cash at beginning of period | 194.47 Million | 191.92 Million | 189.15 Million | 81.54 Million | 91.31 Million | 68.62 Million |
| Cash at end of period | 55.89 Million | 207.34 Million | 191.72 Million | 205.48 Million | 76.8 Million | 93.24 Million |
| Capital Expenditure | -1.35 Million | -1.97 Million | -15.95 Million | -16.46 Million | -25.44 Million | -4.31 Million |
| Effect of forex changes on cash | 2.12 Million | -7.82 Million | 13.45 Million | -15.53 Million | 1.5 Million | 3.28 Million |
| Net cash flow / Change in cash | -138.58 Million | 15.41 Million | 2.56 Million | 123.94 Million | -14.5 Million | 24.61 Million |
| Free Cash Flow | -20.9 Million | 20.92 Million | 20.16 Million | 74.5 Million | 49.11 Million | 41.87 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.51 Million | -60 Thousand | -16.62 Million | -2.03 Million | -9.75 Million | 3.3 Million |
| Depreciation & Amortization | 2.74 Million | -293 Thousand | 5.92 Million | 7.55 Million | 10.18 Million | 2.9 Million |
| Deferred income taxes | - | - | - | 1.23 Million | -45.1 Million | 1.18 Million |
| Stock-based compensation | 2.91 Million | 3.26 Million | 2.42 Million | 3.31 Million | 9.25 Million | 1.96 Million |
| Change in working capital | 7.34 Million | -9.28 Million | -1.04 Million | -1.38 Million | -15.48 Million | -4.56 Million |
| Other non-cash items | -4.77 Million | -4.18 Million | 560 Thousand | 2.88 Million | 31.37 Million | -1.27 Million |
| Investing Cash Flow | 4.35 Million | 36.39 Million | 664 Thousand | -3.9 Million | -119.68 Million | -145.57 Million |
| Investments in PPE | -366 Thousand | -214 Thousand | -80 Thousand | -331 Thousand | -1.35 Million | -147 Thousand |
| Acquisitions | - | - | - | 331 Thousand | - | - |
| Investment purchases | -109.79 Million | -17.67 Million | -94.77 Million | -150.11 Million | -353.35 Million | -214.61 Million |
| Sales/Maturities of investments | 114.51 Million | 56.25 Million | 93.55 Million | 146.36 Million | 215.34 Million | 80 Million |
| Other Investing Activities | -366 Thousand | -2.18 Million | 689.46 Thousand | -155 Thousand | 19.68 Million | -145.42 Million |
| Financing Cash Flow | -1.43 Million | -28.3 Million | -2.47 Million | -1.02 Million | 2.78 Million | 5.24 Million |
| Debt repayment | -1.19 Million | -30.88 Million | -1.32 Million | -1.27 Million | -5.12 Million | -1.27 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 2.38 Million | 814.48 Thousand | 230.32 Thousand | 7.52 Million | 7.9 Million |
| Other Financing Activities | -243 Thousand | 2.58 Million | -1.06 Million | 234.6 Thousand | -4.74 Million | 6.51 Million |
| Accounts receivables | 2.91 Million | -11.46 Million | 6.91 Million | -5.1 Million | -17.14 Million | -6.96 Million |
| Accounts payables | - | 6.58 Million | -8.67 Million | 5.1 Million | 15.01 Million | 6.96 Million |
| Inventory | -2.13 Million | -3.99 Million | 877 Thousand | -3.32 Million | -13.35 Million | -396 Thousand |
| Other working capital | 6.56 Million | 7.13 Million | 28 Thousand | 1.93 Million | -216 Thousand | -4.16 Million |
| Cash at beginning of period | 47.14 Million | 51.89 Million | 61.74 Million | 54.65 Million | 194.47 Million | 192.37 Million |
| Cash at end of period | 60.66 Million | 47.14 Million | 51.89 Million | 61.74 Million | 55.89 Million | 54.65 Million |
| Capital Expenditure | -366 Thousand | -214 Thousand | -80 Thousand | -331 Thousand | -1.35 Million | -147 Thousand |
| Effect of forex changes on cash | 861 Thousand | 381 Thousand | -395 Thousand | 439 Thousand | 2.12 Million | -912 Thousand |
| Net cash flow / Change in cash | 13.52 Million | -4.75 Million | -9.84 Million | 7.08 Million | -138.58 Million | -137.72 Million |
| Free Cash Flow | 9.37 Million | -13.43 Million | -7.72 Million | 11.24 Million | -20.9 Million | 3.38 Million |
EACTF
SRS
LB
BA
CHMI-PA
SGQRF